Alpha Cognition Net Acquisitions/Divestitures 2020-2025 | ACOG

Alpha Cognition net acquisitions/divestitures from 2020 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
Alpha Cognition Annual Net Acquisitions/Divestitures
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.134B $0.000B
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $154.892B 13.19
CSL (CSLLY) Australia $67.141B 0.00
Alnylam Pharmaceuticals (ALNY) United States $58.528B 0.00
Abivax SA (ABVX) France $6.124B 0.00
Alkermes (ALKS) Ireland $4.782B 13.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.714B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.385B 40.61
ADMA Biologics Inc (ADMA) United States $4.119B 29.76
Ascentage Pharma Group - (AAPG) China $3.948B 0.00
Arcellx (ACLX) United States $3.848B 0.00
Akero Therapeutics (AKRO) United States $3.738B 0.00
Apellis Pharmaceuticals (APLS) United States $3.482B 0.00
Alvotech (ALVO) Luxembourg $2.433B 18.34
Agios Pharmaceuticals (AGIO) United States $2.191B 0.00
ANI Pharmaceuticals (ANIP) United States $2.029B 18.19
Adaptive Biotechnologies (ADPT) United States $2.007B 0.00
Apogee Therapeutics (APGE) United States $1.677B 0.00
Celldex Therapeutics (CLDX) United States $1.466B 0.00
Cogent Biosciences (COGT) United States $1.375B 0.00
AbCellera Biologics (ABCL) Canada $1.249B 0.00
CureVac (CVAC) Germany $1.205B 5.59
CorMedix Inc (CRMD) United States $1.107B 19.77
Arbutus Biopharma (ABUS) United States $0.711B 0.00
Castle Biosciences (CSTL) United States $0.696B 68.60
AnaptysBio (ANAB) United States $0.569B 0.00
Cytek Biosciences (CTKB) United States $0.527B 0.00
Alumis (ALMS) United States $0.483B 0.00
Compass Therapeutics (CMPX) United States $0.483B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.428B 0.00
Absci (ABSI) United States $0.357B 0.00
Abeona Therapeutics (ABEO) United States $0.350B 7.42
ADC Therapeutics SA (ADCT) Switzerland $0.345B 0.00
CytomX Therapeutics (CTMX) United States $0.336B 3.64
Amarin (AMRN) Ireland $0.311B 0.00
Contineum Therapeutics (CTNM) United States $0.293B 0.00
Allogene Therapeutics (ALLO) United States $0.251B 0.00
Alector (ALEC) United States $0.238B 0.00
Annexon (ANNX) United States $0.226B 0.00
Adocia (ADOCY) France $0.216B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
Aardvark Therapeutics (AARD) United States $0.180B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.174B 0.00
Citius Oncology (CTOR) United States $0.170B 0.00
Climb Bio (CLYM) United States $0.151B 0.00
Cellectis S.A (CLLS) France $0.143B 0.00
Cardiff Oncology (CRDF) United States $0.140B 0.00
Anika Therapeutics (ANIK) United States $0.135B 0.00
Coherus Oncology (CHRS) United States $0.135B 0.00
Agenus (AGEN) United States $0.133B 0.00
Connect Biopharma Holdings (CNTB) United States $0.115B 0.00
Coya Therapeutics (COYA) United States $0.110B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.103B 0.00
Adagene (ADAG) China $0.100B 0.00
Alto Neuroscience (ANRO) United States $0.100B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
CervoMed (CRVO) United States $0.089B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.082B 0.00
Applied Therapeutics (APLT) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Aligos Therapeutics (ALGS) United States $0.065B 0.00
Adverum Biotechnologies (ADVM) United States $0.065B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.064B 0.00
ALX Oncology Holdings (ALXO) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.060B 0.00
Clene (CLNN) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Allarity Therapeutics (ALLR) United States $0.023B 0.00
Cingulate (CING) United States $0.022B 0.00
Curis (CRIS) United States $0.021B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.019B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.015B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Apollomics (APLM) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00